FY 2024 net revenue of $23.6 million, driven by net revenue of $12.0 million during fourth quarter of 2024Entered into asset purchase agreement ...
FY 2024 net revenue of $23.6 million, driven by net revenue of $12.0 million during fourth quarter of 2024 Entered into asset purchase agreement for sale of PRV for $150 million Company to host confer ...
6don MSN
Some cars had the looks, handling, and appeal but were let down by bad engines. Whether unreliable or underpowered, they fell ...
I know it's part of getting older, but when my husband was told to go to the ER because a clinical trial EKG had revealed an irregular heartbeat, I was startled almost into one of my own.
3d
Top Speed on MSNThe Forgotten French Sports Car That Outran A FerrariVenturi 400 Trophy is a race-bred French machine that out-paces a Ferrari model in the sprint and top speed, but no one is ...
There is a potential regulatory approval risk for the priority review voucher (PRV) associated with RGX-121, which could impact non-dilutive financing options. The competitive landscape in the Wet ...
PRO Real Estate Investment Trust ("PROREIT" or the "REIT") (TSX: PRV.UN) today reported its financial and operating results for the three-month period ("fourth quarter" or "Q4") and fiscal year ...
Full year 2024 total revenues increased by 21% to US$297.2 million and exceeded our guidance, driven by record RUCONEST® revenue and strong ...
Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial ...
Pharming has agreed a deal to sell a recently awarded priority review voucher (PRV) to Novartis for around $21 million - well below the market rate. The price of PRVs, which can be used to shorten ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results